指南与共识皮肤肿瘤

滤泡向性蕈样肉芽肿治疗推荐:荷兰皮肤淋巴瘤组报告

Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group.
指南 / 共识 · Br J Dermatol · 2017-05-11

基于荷兰皮肤淋巴瘤注册库1985-2014年203例滤泡向性蕈样肉芽肿患者的初始治疗结果,早期患者接受标准皮肤导向治疗可获得高缓解率,而晚期患者对皮肤导向治疗反应较差,局部放疗和全身皮肤电子束照射更有效。结论提示不应将所有FMF患者均积极治疗。

要点

  • 早期FMF患者可受益于经典MF常用的标准皮肤导向治疗,预后良好。
  • 晚期FMF对皮肤导向治疗反应较差,局部放疗和全身皮肤电子束照射更有效。
  • 并非所有FMF患者均应接受积极治疗,需区分早期与晚期亚组。

核心结论

  • 早期FMF患者接受标准皮肤导向治疗可获得良好缓解和预后,不应将所有FMF患者均积极治疗。

研究设计与样本

  • 研究纳入荷兰皮肤淋巴瘤注册库1985至2014年间203例FMF患者,其中早期84例、晚期102例、皮肤外FMF 17例,回顾性评估初始治疗类型与结果。

主要发现

  • 早期FMF患者中67/84例接受非积极皮肤导向治疗,外用糖皮质激素单药完全缓解率28%、总缓解率83%。
  • 早期FMF接受UVB治疗完全缓解率0%、总缓解率83%,PUVA治疗完全缓解率30%、总缓解率88%。
  • 晚期FMF患者接受上述皮肤导向治疗合计完全缓解率10%、总缓解率52%。
  • 晚期FMF局部放疗完全缓解率63%、总缓解率100%,全身皮肤电子束照射完全缓解率59%、总缓解率100%,PUVA联合局部放疗完全缓解率5%、总缓解率75%。

临床怎么用

  • 早期FMF可选用外用糖皮质激素、UVB或PUVA等标准皮肤导向治疗。
  • 晚期FMF应优先考虑局部放疗或全身皮肤电子束照射等更积极治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Folliculotropic mycosis fungoides (FMF) is an aggressive variant of mycosis fungoides (MF) and generally less responsive to standard skin-directed therapies (SDTs). Recent studies distinguished indolent (early-stage FMF) and more aggressive (advanced-stage FMF) subgroups. The optimal treatment for both subgroups remains to be defined. OBJECTIVES: To evaluate initial treatment results in patients with early- and advanced-stage FMF. METHODS: A study was undertaken of 203 patients (84 early-stage, 102 advanced-stage, 17 extracutaneous FMF) included in the Dutch Cutaneous Lymphoma Registry between 1985 and 2014. Type and results of initial treatment were retrieved from the Dutch Registry. Main outcomes were complete remission (CR); sustained complete remission; partial remission (PR), > 50% improvement; and overall response (OR; CR + PR). RESULTS: Patients with early-stage FMF were treated with nonaggressive SDTs in 67 of 84 cases resulting, respectively, in CR and OR of 28% and 83% for monotherapy topical steroids, 0% and 83% for ultraviolet B (UVB), and 30% and 88% for psoralen plus ultraviolet A (PUVA). In patients with advanced-stage FMF these SDTs were less effective (combined CR and OR 10% and 52%, respectively). In patients with advanced-stage FMF local radiotherapy (CR 63%; OR 100%), total skin electron beam irradiation (CR 59%; OR 100%) and PUVA combined with local radiotherapy (CR 5%, OR 75%) were most effective. CONCLUSIONS: The results of the present study demonstrate that not all patients with FMF should be treated aggressively. Patients with early-stage FMF may benefit very well from standard SDTs also used in early-stage classic MF and have an excellent prognosis.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. van Santen S, van Doorn R, Neelis KJ, et al. Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group. Br J Dermatol. 2017. PMID: 28132406. doi:10.1111/bjd.15355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。